A Litigation Brief for Physiological Rights

How the claim is filed. Standing, justiciability, remedies, and the defenses to expect. Anchored on the two sample cases (Ferritin 24, John, 68) and on the doctrinal ground of The Instruments Already Exist. A working document for jurists, to be adapted by counsel with the jurisdictional expertise the site does not claim.

The site is written by a clinician-adjacent researcher, not by a jurist. This document is a proto-brief, offered as material for those who do the doctrinal and litigation work. Nothing here substitutes for the jurisdictional adaptation, procedural drafting, and strategic assessment that only counsel with a live matter can supply. What is offered is a map of the claim, its defensible perimeter, the defenses that will be raised against it, and the precedent architecture already in place to support it.

The two sample cases anchor the argument in patients whose files a jurist can visualise. Ferritin 24: A Model Case develops the ordinary iron-insufficiency case in a menstruating woman whose parameter was never ordered. John, 68: A Model Case develops the multi-parameter cognitive-decline case in an elderly man whose six substrate deficits were never examined and whose “early Alzheimer’s” diagnosis rested on that omission. The doctrinal foundation is developed in The Instruments Already Exist. The polemical position is developed in Rights-Based Medicine vs Evidence-Based Medicine.

The rest of the piece assumes those pieces have been read.

The claim, reduced to its structural form

Any physiological rights complaint contains five elements.

One, a documented physiological deficit in the claimant, at a value below a functional threshold identified in the international literature, and measurable by tests already available in commercial laboratories.

Two, a health system to which the claimant has a right of access under the relevant national and international instruments.

Three, a failure by that system either to test the parameter at the granularity the physiology requires, or to correct the parameter once tested, or both.

Four, harm attributable to the omission. This may be a specific clinical harm (a symptom, a disease progression, a diagnosis in an incorrect category), or a diffuse harm to capacity, cognition, mood, or longevity.

Five, a relief sought calibrated to the systemic character of the omission. Individual damages are secondary. The primary relief is an order compelling the system to test and correct the class of parameters at issue, in the class of patients presenting with the claimant’s clinical picture.

The complaint is not a claim of medical error against an individual physician. It is a claim that the standard of care of the health system fails the right the claimant is owed. The distinction is doctrinally load-bearing and returns at every point of the defense analysis.

Standing

Standing analyses are jurisdiction-specific. Four archetypes recur across the receptive systems.

Individual claimant. The patient herself, on her own behalf. This is the simplest configuration and is available in every jurisdiction that recognises the right of access to health services. Jane’s case takes this form.

Familial or representative claimant. Where the primary claimant lacks capacity, a family member, guardian, or representative can file. John’s case takes this form: his wife and son bring the claim in his name and in the name of the class of similarly situated patients. In South African law, Section 38 of the Constitution recognises this broad standing. Colombian tutela permits any person to file on behalf of another. Indian PIL permits any citizen to raise the matter.

Class or representative action. Where a class of similarly situated patients can be defined (menstruating women presenting to primary care with symptoms consistent with iron insufficiency; adults over sixty-five referred to memory clinics for cognitive decline), a class action produces broader jurisprudence but requires more organisational infrastructure. Colombia and Brazil have well-developed collective action mechanisms; the United States permits class actions under Rule 23; the United Kingdom has developed group litigation orders.

Public interest litigation. In jurisdictions that recognise it (India, South Africa, Colombia to a partial extent), a matter of public importance can be raised by any citizen or organisation without the traditional personal-injury requirement. This is the appropriate configuration for the strongest structural claims.

Non-governmental organisations, patient advocacy groups, and human rights institutions can file, join as co-claimants, or intervene as amici, depending on the procedural rules of the jurisdiction. In the United States, standing under Article III requires demonstration of personal injury, causation, and redressability, which constrains the shape of a federal claim but does not foreclose state-level or administrative-law routes.

Justiciability

Two objections dominate the justiciability analysis and must be met at the threshold of any physiological rights claim.

The political question / separation of powers objection. The State will argue that the setting of clinical standards, of drug reimbursement lists, of testing protocols, is properly the executive’s function, and that a court intruding on this domain violates the separation of powers.

The reply is that the court is not being asked to design the health system. It is being asked to determine whether the existing standard fails a right. Courts do this regularly in fields as complex as environmental regulation, competition law, and constitutional review of administrative action. Minister of Health v. Treatment Action Campaign (South Africa, 2002) rejected this defense in the strongest possible terms. The Constitutional Court held that the State’s refusal to make nevirapine available for prevention of mother-to-child HIV transmission was not shielded by executive discretion and could be directly compelled by judicial order. The methodology developed there for evaluating whether State policy is a “reasonable measure” under Section 27 is directly transferable to the physiological rights claim.

The progressive-realization objection. The State will invoke Article 2(1) of the ICESCR: economic and social rights are to be realised “progressively” and “to the maximum of its available resources.” The argument is that judicial enforcement of specific health interventions collapses the discretion the treaty grants to States on the pace of realisation.

The reply, developed in General Comment 3 (1990) and reinforced in General Comment 14 (2000), is that a minimum core of obligations is immediate and not subject to progressive realisation. General Comment 14, at paragraph 43, identifies core obligations including provision of essential drugs (as defined by the WHO Model List) and equitable distribution of health facilities and services. Testing and correcting a documented deficiency in a substance on the Model List, at cost trivial relative to any State health budget, sits inside the minimum core, not inside the progressively-realizable zone. The doctrine has been developed extensively in Colombian, Indian, and Brazilian jurisprudence.

Additional considerations. The claim can be framed at the level where scientific consensus is unambiguous (ferritin below 15, 25-OH-D below 20 ng/mL, homocysteine above 15 μmol/L). The contested-threshold zone can be reserved for later litigation. This scoping choice removes the “the parameters are contested” defense from the first wave of cases.

Remedies

The remedies architecture available in a physiological rights case ranges from the narrow individual order to the structural systemic order. Selection is strategic.

Individual relief. An order compelling the health system to test and correct the specific claimant’s parameters. Simple, discrete, high probability of success in receptive jurisdictions. Sets a precedent that can be built upon but does not, on its own, change the standard.

Class relief. An order extending the individual remedy to a defined class of similarly situated patients. Higher institutional resistance but larger impact per case. The class definition is where a substantial share of the doctrinal work sits.

Structural relief. An order compelling the health system to update its clinical protocols, its testing guidelines, or its reimbursement schedules to include the physiological parameters and their correction. The court retains a supervisory role over compliance. This is the strongest and most transformative remedy. TAC and the Colombian tutela T-760/08 are the archetypes.

Declaratory relief. A ruling that the existing standard of care fails the AAAQ framework and constitutes a violation of the right, without a specific compliance order. Useful as a doctrinal foundation for further litigation or as leverage in legislative and regulatory processes.

Damages. Where jurisdictionally permitted, damages for the harm attributable to the omission. Iatrogenic harm (the cholinesterase inhibitor prescribed to John in place of B-vitamin correction, with the risks and costs the drug carries) can ground a specific damages claim where the omission and the alternative can both be documented. Damages are usually secondary to the corrective and structural remedies.

The strongest first-wave litigation strategy combines an individual or familial claim with a request for structural relief that extends beyond the claimant. This is the shape TAC took. It is the shape the Colombian tutela jurisprudence has consolidated. It is the shape Grootboom and its progeny have made possible in South African housing law.

Anticipated defenses, and how to meet them

Seven defenses are near-certain to be raised. Each has a reply that has been developed elsewhere in the doctrinal literature.

Defense one: there is no evidence.

The State will argue that the intervention has not been proven effective in randomised controlled trials against the specific disease endpoint the claimant invokes. This is the standard reflex analysed at length in Rights-Based Medicine vs Evidence-Based Medicine.

The reply operates at two levels. At the level of the claim, the physiological rights argument does not depend on the intervention preventing a specific disease. It depends on the physiological need being documented and the correction being technically available. Both are uncontested. At the level of the evidence base, the RCT-of-disease-endpoint standard is a filter the funding architecture is structured to withhold in the case of substances that cannot be exclusively licensed. Its absence is a feature of the funding structure, not of the physiology. The court is not being asked to grade the biomedical evidence; it is being asked to determine whether a documented deficit at a substance on the WHO Model List, correctable at low cost, falls within the core obligations of the right to health.

Defense two: the standard of care was met.

The State will argue that no medical error occurred, that the clinicians followed guidelines, and that no violation can arise from adherence to the standard.

The reply is that the physiological rights claim is not a medical error claim. It is a claim that the standard itself fails the AAAQ framework. Adherence to a standard that fails the right does not immunise the standard. The doctrinal architecture of General Comment 14 makes acceptability and quality assessable at the level of the practice architecture, not merely at the level of the individual consultation.

Defense three: resource constraints and progressive realization.

Already addressed under justiciability. The minimum-core doctrine is the pivot. In addition, the cost-benefit direction of the correction (Jane’s ferric maltol against her decade of lost working capacity; John’s B-vitamins against his residential-care trajectory) can be documented in cost-benefit modelling submitted as evidence. In every credible model, the correction saves the State money.

Defense four: clinical autonomy.

The State will argue that what parameter is tested, what value is treated, what dose is given, are matters of clinical judgment that lie beyond the reach of judicial order.

The reply is that the claim does not challenge specific decisions in specific consultations. It challenges the architecture within which those decisions are made possible. Courts intervene in analogous domains without displacing clinical judgment: malpractice law, professional discipline, informed consent, refusal-of-treatment jurisprudence. Requiring the health system to include specific tests and specific interventions in its standard of care leaves the treating physician the full range of judgment within that standard.

Defense five: polycentricity.

The State will invoke Fuller’s classic argument: a case with many downstream ramifications is not suitable for judicial resolution because the court cannot see all the consequences of its ruling.

The reply is that TAC dismissed this argument directly. The Constitutional Court crafted a narrow structural order that respected institutional expertise while requiring compliance with the right. The line of cases from Grootboom through TAC to the T-760/08 tutela has developed a methodology for structural relief that manages the polycentricity concern without abdicating enforcement. The recent climate cases (Urgenda, Milieudefensie) have extended the same methodology to systemic-underperformance orders in domains at least as complex as health.

Defense six: the parameters are contested.

The State will argue that the functional thresholds proposed by the claimant (ferritin 30 rather than 15, 25-OH-D 40 ng/mL rather than 20, homocysteine 8 rather than 15) are contested in the scientific literature, and that a court is not competent to arbitrate the scientific debate.

The reply is scoping. The claim can be framed at the level where the scientific consensus is unambiguous: ferritin below 15 in a symptomatic menstruating woman, 25-OH-D below 20 ng/mL, homocysteine above 15 μmol/L, Omega-3 Index below 4 %. These thresholds are not contested. The claim, framed in the uncontested zone, is defensible on the scientific merits at every jurisdiction. The contested zone follows the first wave, once the doctrinal architecture has been established.

Defense seven: this is a legislative or regulatory matter, not a judicial one.

The State will argue that the correct forum for updating clinical protocols and reimbursement schedules is the executive or the legislature, and that judicial review displaces the democratic process.

The reply is that judicial review is the reserve mechanism where the executive and the legislature have failed to act over decades in the face of a documented right. The State cannot invoke the democratic process it has ignored to defeat the right its institutions have failed to realise. The argument is at the heart of the Chaoulli decision (Canada, 2005), of the environmental litigation cases, of the Urgenda line. It is available wherever a positive right has been left unrealised through institutional inertia rather than deliberate democratic choice.

Precedent architecture

The following precedents form the architecture on which the physiological rights claim rests. Each has been developed in the receptive jurisdictions and is available for citation.

Minister of Health v. Treatment Action Campaign (South Africa Constitutional Court, 2002). The paradigm case for judicial enforcement of positive obligations under the right of access to health services. The Court unanimously ordered the government to make nevirapine available to prevent mother-to-child HIV transmission, and to develop a comprehensive national plan for the rollout. TAC established that Section 27 of the Constitution is directly justiciable, that structural orders are within the court’s competence, that separation of powers does not shield State inaction, and that the reasonableness of State policy is judicially reviewable. Every physiological rights claim in South Africa builds on TAC. Its methodology transfers to any jurisdiction whose constitution recognises a right of access to health services.

Government of the Republic of South Africa v. Grootboom (2000). The Constitutional Court held that the State’s housing programme, in failing to make provision for people in desperate need, was inconsistent with Section 26. Established that positive social rights are justiciable and that the State’s failure to develop a reasonable programme can be judicially reviewed. Doctrinal companion to TAC.

Sentencia T-760 of 2008 (Colombian Constitutional Court). Consolidated the tutela jurisprudence on the right to health into a structural order requiring the reform of the Colombian health system. The decision draws on years of individual tutela cases in which the Court had compelled specific pharmaceutical deliveries, and reorganises the doctrine into a systemic framework. The mínimo vital concept provides doctrinal shelter for the physiological rights claim. Colombia is the jurisdiction in which a claim on Jane’s or John’s facts is most likely to succeed in the first instance.

Paschim Banga Khet Mazdoor Samity v. State of West Bengal (India, Supreme Court, 1996). The Court held that the right to life in Article 21 includes the right to health, and that the State’s failure to provide emergency medical treatment violated the right. Extensively cited in subsequent PIL health litigation. Establishes the foundation on which a PIL on systematic under-testing of ferritin, D, or B12 in identifiable populations could be built.

People’s Union for Civil Liberties v. Union of India (from 2001). The “right to food” PIL that transformed access to nutrition in India through a series of orders sustained over more than a decade. Established that food security is a component of the right to life under Article 21, and that judicial supervision of executive implementation is feasible over long periods. The methodological analogue for a “right to nutrient sufficiency” PIL.

ADI 3510 (Brazilian Supreme Court, 2008). Established constitutional protection for the therapeutic use of embryonic stem cells, in the frame of the right to health under Article 196. The subsequent line of individual-treatment cases in Brazil has produced tens of thousands of judicial orders for specific pharmaceutical delivery. The Brazilian right-to-health litigation is doctrinally the most developed individual-remedy jurisprudence in the world, though the political tension around its scaling creates uncertainty on structural claims.

Urgenda v. Netherlands (Dutch Supreme Court, 2019). Not a health case, but the leading decision on judicial enforcement of positive obligations against systemic State underperformance. The Court held that the State’s failure to reduce emissions violated its obligations under Articles 2 and 8 of the European Convention on Human Rights. The methodology, in which a court orders a State to remedy systemic underperformance where the science is clear and the political response is inadequate, is directly transferable to a physiological rights claim before the European Court of Human Rights on Article 8 grounds.

Chaoulli v. Québec (Canada, 2005). The Supreme Court of Canada held that Québec’s prohibition on private health insurance violated Section 7 of the Charter (life, liberty, security of the person) in the context of unreasonable delays in the public system. Opened, without fully realising, the doctrinal possibility of positive-rights review under Section 7 in specific circumstances. The doctrinal ground for a Canadian physiological rights claim is prepared but not settled.

General Comment 14 (CESCR, 2000). The interpretative instrument that operationalises Article 12 of the ICESCR. AAAQ, core obligations, and the specific enumeration in paragraph 43. The starting point for the doctrinal argument in every jurisdiction that has ratified the Covenant.

General Comment 12 (CESCR, 1999). The interpretative instrument for Article 11 on the right to food. Paragraph 8 defines adequacy in terms of the nutrient needs of the individual. The doctrinal source for the argument that population-level averages fail the specificity the right requires.

Strategic considerations

Venue selection. In the first wave, litigate where the doctrinal ground is prepared. South Africa (TAC methodology directly applicable), Colombia (tutela mechanism, T-760 architecture), Brazil (individual pharmaceutical order jurisprudence), India (PIL tradition). Second wave: European Court of Human Rights on Article 8 grounds building on Urgenda methodology; Council of Europe Committee of Social Rights on Article 11 grounds. Third wave: Canadian Section 7, French constitutional review, other jurisdictions in which the doctrine requires extension of existing lines rather than direct application.

Class construction. Individual claims are procedurally lighter and produce narrower jurisprudence. Class claims produce broader precedent but require more organisational infrastructure and evidentiary preparation. Public interest litigation combines the two in jurisdictions that permit it. A first-wave litigation strategy might file one individual case (Jane) and one class or PIL case (a cognitive-decline class on John’s model), coordinated so that the individual case establishes the doctrinal foundation and the class case extends it.

Timing. Litigate after regulatory failure, not before. Courts prefer to see administrative pathways exhausted. Litigate when the scientific consolidation is unambiguous in the frame of the claim (ferritin below 15, D below 20 ng/mL, etc.); the contested-threshold litigation follows. Coordinate with public communication strategy: a well-timed media presence around a filing multiplies its doctrinal impact.

Evidentiary preparation. Expert affidavits from clinicians who understand the functional-threshold argument and can articulate it to a court unfamiliar with the physiology. Comparative documentation from jurisdictions where the correction is standard practice. Cost-benefit modelling in the form courts of the venue accept. Patient testimony calibrated to the doctrinal question (Jane’s file, John’s family’s account). Documentation of the funding architecture argument, drawing on the RBM piece and its underlying sources.

Coalition building. The strongest cases are brought by coalitions: a patient claimant, a public interest organisation, an academic clinical group, a human rights body as amicus, patient advocacy organisations for outreach. The composition of the coalition is a doctrinal signal to the court about the seriousness of the claim.

An invitation, not a prescription

This document is a beginning. Every element in it is available for adaptation by counsel with knowledge of the specific jurisdiction, the specific court, the specific procedural rules, and the specific factual configuration of a live matter. Nothing here forecloses the strategic choices that must be made in the drafting room and the courtroom.

The physiological substrate has been done, or is being done, in the rights collection of this site. The doctrinal ground is developed in The Instruments Already Exist. The sample cases give the operational shape. What remains is the work of counsel who will translate this material into filings that a court can act on.

The invitation is direct. The instruments exist. The claim is defensible. The precedents are in place. What has been missing is the ally who will file. This document is written to lower one of the barriers between the argument and the filing. The others fall to the jurists who take it up.